Zhongda'an: Wu Junye, the controlling shareholder, plans to reduce his holdings by no more than 2%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

ZEEKR MAKES PARIS MOTOR SHOW DEBUT ON THE BACK OF 200% YEAR ON YEAR GROWTH IN EUROPE

The brand sets out its long-term commitment to Europe and expansion plans, and unveils the Zeekr 9X, its first luxury model, reflecting its New Class of Luxury vision, alongside the all-new Zeekr 7X, to European automotive audiences.

Runjian Signs US$200 Million Overseas AI Inference Contract, Keeping Computing Resources in China

Runjian（润建股份）disclosed on October 18 that its wholly owned subsidiary Wuxiang Yungu（五象云谷）had signed a one-year AI token services contract with an unidentified overseas company. The agreement includes a US$200 million minimum annual purchase commitment, equivalent to approximately CNY 1.338 billion, with computing resources hosted in China and services accessed remotely through an API.

China Proposes Export Restrictions on 23 AI Technologies, Keeps API Services Outside Large-Model Transfer Rules

China’s Ministry of Commerce and Ministry of Science and Technology published proposed additions to the country’s technology-export catalogue on October 16, covering 23 AI technologies. Accompanying guidance distinguishes transfers of restricted technology from services such as overseas API access, while a temporary registration requirement has already taken effect.

Semight Instruments Plans Hong Kong Listing to Broaden Offshore Financing Options

Semight Instruments（联讯仪器）, a Suzhou-based supplier of test instruments and equipment, has secured board approval to pursue an H-share listing on the Hong Kong Stock Exchange’s Main Board. The proposal advances the company’s plans to broaden offshore financing access, although shareholder approval and regulatory procedures remain outstanding.